Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin Uptake Inhibitors | 5 | 2013 | 1426 | 0.710 |
Why?
|
| Fluoxetine | 4 | 2005 | 756 | 0.540 |
Why?
|
| Electroconvulsive Therapy | 6 | 2006 | 444 | 0.450 |
Why?
|
| Paroxetine | 3 | 2003 | 171 | 0.420 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 325 | 0.420 |
Why?
|
| Citalopram | 1 | 2013 | 410 | 0.380 |
Why?
|
| Affect | 1 | 2013 | 1494 | 0.270 |
Why?
|
| Brain Chemistry | 3 | 2005 | 1015 | 0.240 |
Why?
|
| Depressive Disorder | 5 | 2005 | 3804 | 0.210 |
Why?
|
| Fluorine | 1 | 2000 | 83 | 0.200 |
Why?
|
| Brain | 6 | 2013 | 25208 | 0.190 |
Why?
|
| Blood Volume | 1 | 2001 | 587 | 0.190 |
Why?
|
| Prefrontal Cortex | 2 | 2003 | 2046 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2003 | 2744 | 0.130 |
Why?
|
| Double-Blind Method | 5 | 2013 | 11945 | 0.110 |
Why?
|
| Body Fluids | 2 | 2008 | 309 | 0.090 |
Why?
|
| Fludrocortisone | 1 | 2008 | 23 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 699 | 0.090 |
Why?
|
| Glucose | 1 | 2001 | 4270 | 0.090 |
Why?
|
| Depressive Disorder, Major | 2 | 2003 | 4454 | 0.090 |
Why?
|
| Cyproheptadine | 1 | 1987 | 20 | 0.080 |
Why?
|
| Nifedipine | 1 | 2008 | 218 | 0.080 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1987 | 149 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 34430 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2015 | 0.080 |
Why?
|
| Face | 1 | 2013 | 977 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2013 | 2014 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2005 | 3687 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2222 | 0.070 |
Why?
|
| Epilepsia Partialis Continua | 1 | 2005 | 20 | 0.070 |
Why?
|
| Vaginal Smears | 1 | 2008 | 499 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2005 | 638 | 0.060 |
Why?
|
| Photometry | 1 | 2004 | 57 | 0.060 |
Why?
|
| Sodium | 2 | 2008 | 1599 | 0.060 |
Why?
|
| Tomography, Optical | 1 | 2004 | 134 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 427 | 0.060 |
Why?
|
| Leg | 1 | 2008 | 1115 | 0.060 |
Why?
|
| Infrared Rays | 1 | 2004 | 258 | 0.060 |
Why?
|
| Choline | 1 | 2003 | 472 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 4931 | 0.050 |
Why?
|
| Oxygen | 1 | 2013 | 4162 | 0.050 |
Why?
|
| Muscles | 1 | 2006 | 1556 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 402 | 0.050 |
Why?
|
| Protons | 1 | 2006 | 1065 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2399 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2001 | 299 | 0.050 |
Why?
|
| Adult | 14 | 2013 | 212279 | 0.050 |
Why?
|
| Lithium | 1 | 2002 | 615 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 621 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2005 | 617 | 0.040 |
Why?
|
| Genotype | 1 | 2013 | 12919 | 0.040 |
Why?
|
| Idazoxan | 1 | 1997 | 9 | 0.040 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 1997 | 11 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2001 | 1147 | 0.040 |
Why?
|
| Gyrus Cinguli | 1 | 2003 | 1070 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2006 | 5054 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 11201 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 9004 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 1974 | 0.040 |
Why?
|
| Placebos | 1 | 2000 | 1735 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2004 | 1781 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2005 | 1311 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2005 | 6447 | 0.030 |
Why?
|
| Male | 12 | 2013 | 350352 | 0.030 |
Why?
|
| Reference Values | 1 | 2001 | 5050 | 0.030 |
Why?
|
| Humans | 18 | 2013 | 715818 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2001 | 2025 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2006 | 3317 | 0.030 |
Why?
|
| Arousal | 1 | 1997 | 1140 | 0.030 |
Why?
|
| Female | 12 | 2008 | 377229 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2001 | 2757 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2001 | 8075 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 19537 | 0.020 |
Why?
|
| Middle Aged | 5 | 2013 | 214666 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2008 | 115 | 0.020 |
Why?
|
| Arterioles | 1 | 1987 | 251 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 604 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 2259 | 0.020 |
Why?
|
| Cervical Intraepithelial Neoplasia | 1 | 2008 | 307 | 0.020 |
Why?
|
| Microspheres | 1 | 1987 | 794 | 0.020 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1984 | 87 | 0.020 |
Why?
|
| Absorption | 1 | 2004 | 268 | 0.020 |
Why?
|
| Forehead | 1 | 2004 | 72 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 1984 | 286 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40887 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2008 | 696 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 2003 | 214 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 276 | 0.010 |
Why?
|
| Diffusion | 1 | 2004 | 835 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 946 | 0.010 |
Why?
|
| Rabbits | 1 | 1987 | 5060 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2003 | 603 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2006 | 1375 | 0.010 |
Why?
|
| Safety | 1 | 2005 | 1217 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1984 | 1248 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 733 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2004 | 6539 | 0.010 |
Why?
|
| Adolescent | 4 | 2008 | 85157 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3193 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1930 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 51317 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2003 | 2288 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 3066 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 1755 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1997 | 912 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 5030 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 6183 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 2292 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1997 | 701 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1987 | 5694 | 0.010 |
Why?
|
| Rats | 1 | 1987 | 24852 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6105 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 3413 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 5805 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1987 | 18197 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15198 | 0.000 |
Why?
|
| Child | 2 | 2005 | 74468 | 0.000 |
Why?
|
| Age Factors | 1 | 2002 | 18787 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1984 | 774 | 0.000 |
Why?
|
| Sex Factors | 1 | 1997 | 10666 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 58326 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1997 | 8544 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1984 | 1420 | 0.000 |
Why?
|
| Animals | 2 | 1987 | 169404 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 62040 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 162468 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1984 | 2985 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1984 | 2995 | 0.000 |
Why?
|
| Mice | 1 | 1984 | 80373 | 0.000 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_